Access Program Information
The purpose of this study is to provide Sildenafil therapy for subjects who completed
A1481156 study and are judged by the investigator to derive clinical benefit from continued
treatment with Sildenafil, prior to reimbursement and availability for subjects in the
Russian Federation.